US 11261190
Dihydropyrimidine compounds and uses thereof in medicine
granted A61KA61K31/506A61K45/06
Quick answer
US patent 11261190 (Dihydropyrimidine compounds and uses thereof in medicine) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/506, A61K45/06, A61P, A61P1/16